Ghp Investment Advisors, Inc. Astrazeneca PLC Transaction History
Ghp Investment Advisors, Inc.
- $2.15 Billion
- Q3 2024
A detailed history of Ghp Investment Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Ghp Investment Advisors, Inc. holds 449 shares of AZN stock, worth $30,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
449
Previous 329
36.47%
Holding current value
$30,361
Previous $25,000
36.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.25 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.84 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.52 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.49 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.29 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $210B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...